跳至主要内容
临床试验/IRCT20140818018842N14
IRCT20140818018842N14已完成3 期

The randomized single-blinded clinical trial comparing growth hormone effect versus placebo on Improving the outcome of pregnancy in infertile patients.

Deputy of Research and Technology, Tehran University of Medical Sciences.0 个研究点目标入组 105 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
Female

入选标准

  • Sign the informed consent form
  • Patients with poor ovarian response based on criteria provided by the Union embryology and infertility Europe 2011.
  • Strong history of poor ovarian response (Having a maximum of three ovum after inducing ovulation protocols)
  • Low score ovarian reserve (AFC less than 7, AMH less than 0.5-1.1 ng/ml)

排除标准

  • Women with high levels of FSH (more than 20 IU/L)
  • Women with a history of infertility due to known non poor ovarian resonce
  • Women with diabetes (type I or II)

研究者

发起方
Deputy of Research and Technology, Tehran University of Medical Sciences.

相似试验